Skip to main content

Utility Menu

  • Heart Failure Awareness Week
  • COVID-19
  • Meetings
  • News
  • Journal
  • Learning Center
  • Member Login
Home

Main navigation

  • About Us
    • Board of Directors
    • Committees
    • Event Endorsement Guidelines
    • Financials
    • HFSA Staff
    • Sponsorship
    • Strategic Plan
  • Membership
    • Join or Renew
    • Membership Benefits and Types
    • Membership Directory
    • Member Login
    • Corporate Membership
  • Professional Development
    • Awards
    • Continuing Education
      • HFSA Virtual Annual Scientific Meeting 2020
      • HFSA Virtual Board Certification Review 2020
    • Heart Failure Certification (HF-Cert)
    • Fellowship Designation Program (FHFSA)
    • ERAS/NRMP Match for AHFTC Fellowship
    • HFSA Career Center
    • HFSA Learning Center
    • Heart Failure Beat Podcast
    • Professional Development News
  • Research
    • Heart Failure Beat Podcast
    • Journal of Cardiac Failure
    • Published Papers & Guidelines
    • Surveys
    • HFSA Research Network
    • Industry News
  • Advocacy
  • Patient Hub
    • Additional Resources for Patients
    • Heart Failure Awareness 365
    • Heart Failure Beat Healthy Living Podcast
    • Heart Failure Clinical Trials Search
    • Heart Failure Facts
    • Heart Failure Patient and Caregiver Day 2020
    • Patient News
    • Patient Tools
    • Patient Resources for Providers
    • HFSA Coronavirus (COVID-19) Resources
  • Coronavirus (COVID-19) Resources
  • Heart Failure Awareness Week
  • COVID-19
  • Meetings
  • News
  • Journal
  • Learning Center
  • Member Login
Facebook
Youtube
Twitter
Linkedin

Breadcrumb

  1. Home
  2. News

News

Feb
19
2021 |

Novartis Entresto® granted expanded indication in chronic heart failure by FDA

Industry News
Industry
Read More
Jan
22
2021 |

Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)

Industry News
Industry
Read More
Jan
13
2021 |

US FDA accepts supplemental New Drug Application for Jardiance® (empagliflozin) for adults with heart failure with reduced ejection fraction

Industry News
In The News
Industry
Read More
Oct
27
2020 |

New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status

Industry News
Industry
Read More
Oct
13
2020 |

Amgen, Cytokinetics And Servier Announce Topline Results From GALACTIC-HF, A Phase 3 Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

Industry News
Industry
Read More

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Next page Next ›
  • Last page Last »

Leading experts on heart failure care

Our vision is to significantly reduce the burden of heart failure and provide a platform for collaboration, education, innovation, research, and advocacy to improve and expand care.

Learn more About HFSA

Get in touch

9211 Corporate Blvd., Suite 270 Rockville, MD 20850
(301) 312-8635
info@hfsa.org
Facebook
Youtube
Twitter
Linkedin

Footer menu

  • Contact
  • Media Center
  • Privacy Policy & Terms of Use